T11	Exp 121 148	The proteolytic degradation
T12	Exp 152 174	the inhibitory protein
T13	Exp 263 277	the activation
T14	Exp 281 317	the transcription factor NF-kappa B.
T15	Exp 429 433	that
T16	Exp 330 344	the expression
T17	Exp 442 471	the endogenous murine protein
T18	Exp 645 654	the cells
T19	Exp 660 709	the proteasome inhibitor N-Ac-Leu-Leu-norleucinal
T20	Exp 833 866	the human I kappa B alpha protein
T21	Exp 719 750	this ligand-induced degradation
T22	Exp 935 937	we
T23	Exp 996 1000	both
T24	Exp 898 915	the human protein
T25	Exp 966 979	the sequences
T26	Exp 1001 1035	the ligand-induced phosphorylation
T27	Exp 1040 1055	the degradation
T28	Exp 919 933	this cell line
T29	Exp 1076 1087	Our results
T30	Exp 1093 1097	that
T31	Exp 1110 1124	the C terminus
T32	Exp 1128 1156	the I kappa B alpha molecule
T33	Exp 1310 1314	that
T34	Exp 1442 1446	that
T35	Exp 1315 1344	the inducible phosphorylation
T36	Exp 1387 1401	the N terminus
T37	Exp 1405 1416	the protein
T38	Exp 1447 1459	the mutation
T39	Exp 1609 1620	the protein
T40	Exp 1463 1477	either residue
T41	Exp 1539 1552	both residues
R4	Coref Anaphora:T17 Antecedent:T5
R5	Coref Anaphora:T24 Antecedent:T20
R6	Coref Anaphora:T37 Antecedent:T10
R7	Coref Anaphora:T39 Antecedent:T10
T1	Protein 51 55	MAD3
T2	Protein 56 71	I kappa B alpha
T3	Protein 175 179	MAD3
T4	Protein 180 195	I kappa B alpha
T5	Protein 354 369	I kappa B alpha
T6	Protein 483 498	I kappa B alpha
T7	Protein 843 858	I kappa B alpha
T8	Protein 1059 1074	I kappa B alpha
T9	Protein 1132 1147	I kappa B alpha
T10	Protein 1348 1363	I kappa B alpha
